• MustGrow closed a non-brokered private placement, issuing 7,481,541 units at CAD 0.5 for gross proceeds of about CAD 3.74 million.
• Each unit includes one common share, one warrant exercisable for 60 months at CAD 0.7 per share.
• Net proceeds earmarked for TerraSante inventory production, working capital, general corporate purposes.
• Eligible finders received CAD 110,865 cash fees, 221,730 finder’s warrants exercisable at CAD 0.7 for 60 months.
• Offering remains subject to final TSX Venture Exchange approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MustGrow Biologics Corp. published the original content used to generate this news brief on June 19, 2026, and is solely responsible for the information contained therein.